Effect of experimental renal dysfunction on bioavailability of ajmaline in rats

Journal of Pharmacy and Pharmacology

Volumn 53, Issue 6, 2001, Pages 805-813

  Hashimoto, Y ^a   Aiba, T ^a   Yasuhara, M ^b   Hori, R ^c  

^a UNIVERSITY OF TOYAMA   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c KINKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AJMALINE; URANYL NITRATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG INFUSION; EXPERIMENTAL MODEL; FIRST PASS EFFECT; KIDNEY CLEARANCE; KIDNEY DISEASE; LIVER CELL; LIVER METABOLISM; MALE; NONHUMAN; PORTAL VEIN; RAT; REFERENCE VALUE; SMALL INTESTINE ABSORPTION; SUPERNATANT;

ABSORPTION; AJMALINE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BIOLOGICAL AVAILABILITY; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INTESTINE, SMALL; KIDNEY DISEASES; LIVER; MALE; RATS; RATS, WISTAR;

EID: 0034986976     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357011776153     Document Type: Article

References (32)

1. Influence of renal failure on the hepatic clearance of bufuralol in man
2. Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment
3. The effects of ajmaline in experimental and clinical arrhythmias and their relation to some electrophysiological parameters of the heart
4. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
5. Pindolol availability in hypertensive patients with normal and impaired renal function
6. Carrier-mediated transport of ouabain in isolated hepatocytes
7. Influence of renal disease on pharmacokinetics
8. Pharmacokinetics of d-propoxyphene in anephric patients
9. Pharmacokinetics and antiarrhythmic activity of ajmaline in rats subjected to coronary artery occlusion
10. Pharmacokinetics and dromotropic activity of ajmaline in rats with hyperthyroidism
11. Effects of intestinal and hepatic metabolism on the bioavailability of tacrolimus in rats
12. Quinidine-induced rise in ajmaline plasma concentration
13. Reduced hepatic uptake of propranolol in rats with acute renal failure
14. The pharmacokinetics and organ distribution of ajmaline and quinidine in the mouse
15. Increased availability of propranolol in rats with uranyl nitrate-induced acute renal failure
16. Effect of experimental acute renal failure on intestinal barriers to drug absorption
17. Ausscheidungsmengen und geschminding-keiten des Rauwolfia-Alkaloids Ajmaline nach Verschiedenen Applikationsformen
18. Altered S-(-)-propranolol disposition in bilateral ureter-ligated rats
19. Pharmacokinetics of oral propranolol in chronic renal disease
20. Effect of acute renal failure upon cell division in the jejunum: Radioautographic and ultrastructural studies in the mouse
21. Pharmacokinetic study of 4-methylumbelliferone in rats: Influence of dose on its first-pass hepatic elimination
22. Pharmacokinetics and bioavailability of tacrolimus in rats with experimental renal dysfunction
23. Regional myocardial ajmaline concentration and antiarrhythmic activity for ischaemia- and reperfusion-induced arrhythmias in rats
24. Pharmacokinetics and electrophysiological effects of intravenous ajmaline
25. Effect of experimental renal failure on the disposition kinetics of l-propranolol in rats
26. Pharmacokinetics of l-propranolol during repetitive dosing in normal and uranyl nitrate-induced renal failure rats
27. Reduced extraction of l-propranolol by perfused rat liver in the presence of uremic blood
28. A physiological approach to hepatic drug clearance
29. Mechanisms of pharmacokinetic interaction between ajmaline and quinidine in rats
30. A pharmacokinetic analysis program (MULTI) for microcomputer
31. Kinetics of ajmaline disposition and pharmacologic response in beagle dogs